| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | August 23, 2021 4:01 P.M. |
| Form: | S-1 | ||||||
| |||||||
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | August 23, 2021 4:01 P.M. |
| Form: | S-1 | ||||||
| |||||||
Save time and jump to the most important pieces.
4 - Markforged Holding Corp (0001816613) (Issuer)
4 - Markforged Holding Corp (0001816613) (Issuer)
4 - Markforged Holding Corp (0001816613) (Issuer)
Markforged Holding Corporation (NYSE:MKFG), creator of the integrated metal and carbon fiber additive manufacturing platform, The Digital Forge, today announced the results of MarkForged, Inc. from the second quarter ended June 30, 2021.1 Financial Highlights Revenue increased by 44.1% to $20.4 million in the second quarter of 2021 from $14.2 million in the second quarter of 2020. Gross profit grew 60.0% to $11.9 million in the second quarter of 2021 from $7.5 million in the second quarter of 2020. Gross margins expanded to 58% in the second quarter of 2021 compared to 53% in the second quarter of 2020. EBITDA was ($10.7) million in the second quarter of 2021. Adjusted EBITDA wa
SC 13G - Markforged Holding Corp (0001816613) (Subject)
SC 13G/A - Markforged Holding Corp (0001816613) (Subject)
SC 13G - Markforged Holding Corp (0001816613) (Subject)
Markforged Holding Corporation (NYSE:MKFG), creator of the integrated metal and carbon fiber additive manufacturing platform, The Digital Forge, today announced the results of MarkForged, Inc. from the second quarter ended June 30, 2021.1 Financial Highlights Revenue increased by 44.1% to $20.4 million in the second quarter of 2021 from $14.2 million in the second quarter of 2020. Gross profit grew 60.0% to $11.9 million in the second quarter of 2021 from $7.5 million in the second quarter of 2020. Gross margins expanded to 58% in the second quarter of 2021 compared to 53% in the second quarter of 2020. EBITDA was ($10.7) million in the second quarter of 2021. Adjusted EBITDA wa
Markforged Begins Trading on July 15 Following Successful Closing of Merger with one SPAC Markforged, Inc., creator of the integrated metal and carbon fiber additive manufacturing platform, The Digital Forge, today announced that it has completed its previously announced merger with one (NYSE:AONE), a special purpose acquisition company sponsored by A-star and founded and led by technology industry veteran Kevin Hartz. The combined company, named Markforged Holding Corporation, is expected to commence trading on the New York Stock Exchange beginning on July 15, 2021 under the ticker symbol "MKFG" for Markforged common stock and "MKFG.WS" for Markforged warrants. Markforged continued its c
INDIANAPOLIS, July 13, 2021 /PRNewswire/ -- Würth Additive Group, a Würth Industry North America company, the leader in physical and digital inventory, today announced that it has signed a global agreement with Markforged, the creator of the Digital Forge, the integrated metal and carbon fiber industrial 3D printing platform. The expanded agreement will incorporate the Digital Forge into Würth Additive Group's additive manufacturing solutions on a global scale. This agreement brings the Digital Forge's combined precise and reliable 3D printing hardware and cloud-based learning
S-8 - Markforged Holding Corp (0001816613) (Filer)
EFFECT - Markforged Holding Corp (0001816613) (Filer)
424B3 - Markforged Holding Corp (0001816613) (Filer)
Lake Street initiated coverage of One with a rating of Buy and set a new price target of $14.00
For Immediate Release: December 18, 2020 Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the second vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The emergency use authorization allows the Moderna COVID-19 Vaccine to be distributed in the U.S. for use in individuals 18 years of age and older. “With the avai
For Immediate Release: December 18, 2020 Today, the U.S. Food and Drug Administration approved Orgovyx (relugolix) for the treatment of adult patients with advanced prostate cancer. “Today’s approval marks the first oral drug in this class and it may eliminate some patients’ need to visit the clinic for treatments that require administration by a health care provider,” said Richard Pazdur, M.D., director of the FDA’s Oncology Center of Exce
For Immediate Release: December 14, 2020 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: Yesterday, the FDA posted the review memorandum outlining the basis of the agency’s decision to authorize the Pfizer-BioNTech COVID-19 Vaccine. To ensure all Americans can have trust and confidence in the carefulness of FDA’s review, we have made, and will continue